Document Detail


The tissue-type plasminogen activator story.
MedLine Citation:
PMID:  19605778     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Milestones in the development of tissue-type plasminogen activator (t-PA) as a fibrin-specific thrombolytic agent include: purification of human t-PA from the culture fluid of the Bowes melanoma cell line, elucidation of the molecular basis of fibrin-specific plasminogen activation, first experimental animal models of thrombosis, first patient (renal allograft) treated with melanoma t-PA, pilot studies in patients with acute myocardial infarction, cloning and expression of recombinant t-PA providing sufficient amounts for large scale clinical use, and demonstration of its therapeutic benefit in large multicenter clinical trials.
Authors:
D Collen; H R Lijnen
Related Documents :
12630278 - Myocardial infarction: signs symptoms and treatment.
2525898 - Nonemergent cardiac catheterization and risk-stratified revascularization following thr...
7893308 - Effect of age on myocardial infarction and thrombolysis.
23885758 - Takotsubo cardiomyopathy could occur in patients with apathetic hyperthyroidism.
10980208 - Usefulness of impaired chronotropic response to exercise as a predictor of mortality, i...
7979858 - Antibody against oxidized low-density lipoprotein predicting myocardial infarction.
Publication Detail:
Type:  Historical Article; Journal Article    
Journal Detail:
Title:  Arteriosclerosis, thrombosis, and vascular biology     Volume:  29     ISSN:  1524-4636     ISO Abbreviation:  Arterioscler. Thromb. Vasc. Biol.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-07-16     Completed Date:  2009-08-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9505803     Medline TA:  Arterioscler Thromb Vasc Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1151-5     Citation Subset:  IM    
Affiliation:
Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, O & N 1, Herestraat 49 Box 911, B-3000 Leuven, Belgium. desire.collen@med.kuleuven.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Fibrinolytic Agents / history*,  therapeutic use
History, 20th Century
Humans
Recombinant Proteins / chemical synthesis,  history,  therapeutic use
Thrombolytic Therapy / history*,  methods
Thrombosis / blood,  drug therapy,  history*
Tissue Plasminogen Activator / chemical synthesis,  history*,  therapeutic use
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; 0/Recombinant Proteins; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association of y chromosome haplotypes with autism.
Next Document:  Androgen receptor antagonism and an insulin sensitizer block the advancement of vaginal opening by h...